SCHEMBL1133347

SCHEMBL1133347

CC(C)OC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1133346 0.97
Hydrochloric Acid SCHEMBL6787736 0.97 LMNA (0.45)
Ethylene Glycol SCHEMBL8008007 0.93 LMNA (0.42)
SCHEMBL10457871 0.89 LMNA (0.39)
Glycerin SCHEMBL8821888 0.87 LMNA (0.38)
SCHEMBL17288283 0.81
SCHEMBL3457795 0.81
Hydrochloric Acid SCHEMBL7701843 0.81 LMNA (0.38)
SCHEMBL4671535 0.81
SCHEMBL18274711 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288583-A1 Treatment of Mucus Hypersecretion ALTA RESEARCH, LLC 2025-09-18 US claimed
CN-119591552-A Method for synthesizing dapest by multicomponent one-pot method 武汉工程大学 2025-03-11 CN claimed
CN-119241445-A Method for preparing dapest by one-pot method 武汉工程大学 2025-01-03 CN claimed
WO-2024255873-A1 METHOD FOR PREPARING ANTIBODY-DRUG CONJUGATE 江苏迈威康新药研发有限公司 2024-12-19 WO claimed
CN-119139490-A Method for preparing antibody drug conjugate 江苏迈威康新药研发有限公司 2024-12-17 CN claimed
CN-118434765-A BCMA monoclonal antibodies and antibody-drug conjugates 杭州多禧生物科技有限公司 2024-08-02 CN claimed
CN-118215676-A Specific conjugation of antibody drug conjugates 杭州多禧生物科技有限公司 2024-06-18 CN claimed
CN-117486878-A Preparation method of ennafilat 扬州市普林斯医药科技有限公司 2024-02-02 CN claimed
EP-4301507-A1 FUNCTIONALISED HYDROGELS Commonwealth Scientific and Industrial Research Organisation (AU) 2024-01-10 EP claimed
WO-2022183244-A1 FUNCTIONALISED HYDROGELS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2022-09-09 WO claimed
CN-105962360-A Method for producing microorganism ferment 山东祥维斯生物科技股份有限公司 2016-09-28 CN claimed
CN-103922987-A Zabofloxacin intermediate and synthetic method thereof. SUZHOU TIANMA SPECIALTY CHEMICALS CO LTD 2014-07-16 CN claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
EP-0861264-A2 COLLAGEN-LIKE PEPTOID RESIDUE-CONTAINING STRUCTURES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-09-02 EP claimed
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 US claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
WO-1997019106-A2 COLLAGEN-LIKE PEPTOID RESIDUE-CONTAINING STRUCTURES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-05-29 WO claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed